• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

A Weight-Loss Drug Has Been Approved For Obese Children 12 And Up

December 30, 2022 by Deborah Bloomfield

A weight-loss drug that’s been shown to encourage weight loss in people with obesity is now available for children as young as 12 in the US. Last week, the US Food and Drug Administration (FDA) approved the drug Wegovy for use in adolescents who are 12 years old or over, according to the drug maker Novo Nordisk.

Adolescents with a BMI in the top 5 percent for their age group will be able to receive a once-weekly injection of the drug along with a plan to reduce their calorie intake and increase levels of physical activity.

Advertisement

Wegovy (aka semaglutide) works by mimicking a hormone called glucagon-like peptide-1 (GLP-1), a hormone produced in the gut and released in response to food. It effectively tells the body your appetite has been satisfied and suppresses your hunger.

The drug was approved by the FDA for use in adults back in June 2021, but this latest approval will make it possible for doctors to prescribe it to some people with obesity under the age of 18. 

The latest approval comes off the back of a phase 3a trial recently published in the New England Journal of Medicine that found adolescents receiving the drug experienced an average 16.1 percent loss in BMI, compared to a 0.6 percent increase in the placebo group. 

Advertisement

“The prevalence of teen obesity in the US continues to rise, affecting teens and their families. Now, more than ever, we need new options to support teens,” Aaron S Kelly, PhD, Co-Director of the Center for Pediatric Obesity Medicine at the University of Minnesota, said in a statement. 

“This FDA approval offers an additional tool to address this serious, chronic, progressive disease,” continued Kelly.

There’s decent research that has indicated it can be a useful tool to help people with obesity lose weight, but some experts have previously warned that no weight-loss drug should be considered a “magic bullet”. When commenting on a 2021 clinical trial of the drug in adults, researchers noted that there are still some reservations about the use of the drug. 

Advertisement

“While drugs like this may prove useful in the short term for obtaining rapid weight loss in severe obesity, they are not a magic bullet for preventing or treating less severe degrees of obesity and public health measures that encourage behavioural changes such as regular physical activity and moderating dietary energy intake are still needed,” said Tom Sanders, Professor Emeritus of Nutrition and Dietetics, King’s College London.

“It is rather like the situation we are in with the vaccine, we still need to stick with public health measures and not become overdependent on medicines,” he explained.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Tennis – Kerber defeats Stephens in the battle of the U.S. Open champs
  2. EU lawmakers call for Lebanon sanctions if new government fails
  3. Vatican hopes its pre-COP26 climate event will raise stakes in Glasgow
  4. Why Do People Have Slips Of The Tongue?

Source Link: A Weight-Loss Drug Has Been Approved For Obese Children 12 And Up

Filed Under: News

Primary Sidebar

  • 40,000-Year-Old Mammoth Ivory Boomerang And Human Finger Hint At Mysterious Prehistoric Rituals
  • 99-Million-Year-Old Amber Fossils Mark The Oldest Known Example Of “Zombie Fungus” Infection
  • Breakthrough Qubit Control Near Absolute Zero Is Scalability Game-Changer For Quantum Computing
  • “On A Timescale Of Millions Of Years”: Scientists Detect Pulsing “Heartbeat” Under Africa
  • Skin Moles: What Are They And When Should You Get Them Checked?
  • 20 New Bat Viruses – Some “Cousins” Of Deadly Hendra And Nipah – Spark Fears Of Human Disease
  • “Nobody Expected This”: Earth’s Rotation Will Speed Up In July And August, Bucking The Downward Trend
  • What Is The “Heat Dome” Causing Baking Temperatures In The Eastern US This June?
  • Over 500 Bird Species At Risk In Next Century As We Face “Unprecedented” Extinction Crisis
  • World First: Mice With 2 Dads Father Their Own Offspring
  • Largest Ever Space-Based Gravitational Wave Observatory Begins Construction
  • Plastic Trash? This Bacterium Can Turn It Into Paracetamol – AKA Tylenol®
  • What Is The Earliest Evidence For Blue Eyes In Humans?
  • Now 124 Years Old, Henry Is The World’s Oldest Known Crocodile – And He’s A Big Boy
  • What Happened When A Kansas Family Lived With 2,055 Brown Recluse Spiders For 5 And A Half Years
  • The Last Thing A NASA Spacecraft Saw Before Plunging Into Saturn
  • Neolithic Ireland Wasn’t Ruled By Incestuous “God-Kings” After All
  • NASA’s Voyager 1 & 2 Were Not The First Missions To Reach The Outer Solar System
  • See Incredible First Images From Space Mission That Will Weigh All The World’s Forests
  • Nudes Of The Stone Age: 6,000-Year-Old Kołobrzeg Venus Is A Prehistoric Masterpiece
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version